首页> 美国卫生研究院文献>Journal of Medicinal Food >Effect of Tomato Industrial Processing (Different Hybrids Paste and Pomace) on Inhibition of Platelet Function In Vitro Ex Vivo and In Vivo
【2h】

Effect of Tomato Industrial Processing (Different Hybrids Paste and Pomace) on Inhibition of Platelet Function In Vitro Ex Vivo and In Vivo

机译:番茄工业加工(不同杂种浆糊和果渣)对体外离体和体内抑制血小板功能的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiovascular disease (CVD) is the leading cause of death worldwide. Healthy eating is among its safeguards, especially the daily intake of fruits and vegetables. In this context it has been shown that tomato (Solanum lycopersicum) presents antiplatelet activity. In the present study, we evaluated in vitro antiplatelet activity of fresh hybrid tomato process (nine hybrids: Apt 410, H 9888, Bos 8066, Sun 6366, AB3, HMX 7883, H 9665, H 7709, and H 9997), paste and its by-product of industrial processes (pomace). We assessed antiplatelet activity ex vivo and bleeding time in rats that ingested 0.1 and 1.0 g/kg of pomace each day. In studies in vitro, no significant differences in antiplatelet activity was observed in fresh tomato hybrids. Furthermore, the agro-industrial process did not affect the antiplatelet activity of paste and pomace. Likewise, pomace intake of 1.0 g/kg per day prolonged bleeding time and reduced ex vivo platelet aggregation in rats. The data obtained indicate that tomato has one or more compounds that caused antiplatelet activity. Regular consumption of tomato and its industrial derivatives could be part of a CVD prevention regimen.
机译:心血管疾病(CVD)是全球死亡的主要原因。健康饮食是其保障措施之一,尤其是日常摄入的水果和蔬菜。在这种情况下,已经显示出番茄(番茄)具有抗血小板活性。在本研究中,我们评估了新鲜杂交番茄过程(九个杂交品种:Apt 410,H 9888,Bos 8066,Sun 6366,AB3,HMX 7883,H 9665,H 7709和H 9997)的体外抗血小板活性。它是工业过程的副产品(果渣)。我们评估了每天摄入0.1和1.0μg/ kg果渣的大鼠的离体抗血小板活性和出血时间。在体外研究中,在新鲜番茄杂种中未观察到抗血小板活性的显着差异。此外,农业工业过程不影响糊状物和果渣的抗血小板活性。同样,每天摄入1.0μg/ kg的果渣会延长出血时间,并减少大鼠的离体血小板聚集。获得的数据表明番茄具有一种或多种引起抗血小板活性的化合物。定期食用番茄及其工业衍生物可能是CVD预防方案的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号